(2005). Aikou T: Lymphatic invasion using D2-40 monoclonal antibody and its relationship to lymph node micrometastasis in pN0 gastric cancer.
(2003). Akslen LA: Independent prognostic impact of lymphatic vessel density and presence of low-grade lymphangiogenesis in cutaneous melanoma.
(2005). Cao Y: Vascular endothelial growth factor-A promotes peritumoral lymphangiogenesis and lymphatic metastasis. Cancer Res
(2002). Carmeliet P: Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell
(2005). Chayama K: Expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in early gastric carcinoma: correlation with clinicopathological parameters. Cancer Lett
(2002). DG: Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. Cancer Res
(2006). et al: Evaluation of lymphatic invasion in primary gastric cancer by a new monoclonal antibody, D2-40. Hum Pathol
(2005). From L: Detection of lymphatic invasion in primary melanoma with monoclonal antibody D2-40: a new selective immunohistochemical marker of lymphatic endothelium. Arch Dermatol
(2005). High lymphatic vessel density correlates with overexpression of VEGF-C in gastric cancer. Oncol Rep
(2010). HS: Increased intratumoral lymphatic vessel density correlates with lymph node metastasis in early gastric carcinoma. Ann Surg Oncol
(2008). Iguchi Tomohiro, Taguchi Kenichi, Taketomi Akinobu, Yoshihiko Maehara, Tsuneyoshi Masazumi: Lymphatic spread is related to VEGF-C expression and D2-40-positive myofibroblasts in intrahepatic cholangiocarcinoma. Modern Pathology
(2003). Intratumoral lymphatics and lymph node metastases in papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg
(2003). Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck region. Cancer Res
(2004). Klöppel G: Expression of lymphangiogenic factors and evidence of intratumoral lymphangiogenesis in pancreatic endocrine tumors.
(2008). Lymph vascular invasion in invasive mammary carcinomas identified by the endothelial lymphatic marker D2-40 is associated with other indicators of poor prognosis.
(2009). Lymphangiogenesis in gastric carcinoma correlates with prognosis.
(2006). Lymphatic endothelial cells, tumor lymphangiogenesis and metastasis: New insights into intratumoral and peritumoral lymphatics. Cancer Metastasis Rev
(2005). Role of VEGF-C and VEGF-D in lymphangiogenesis in gastric cancer.
(2007). SG: Prognostic significance of vascular endothelial cell growth factors -A, -C and -D in breast cancer and their relationships with angio- and lymphangiogenesis.
(2008). Sun YL: Clinicopathological significance of peritumoral lymphatic vessel density in gastric carcinoma. Cancer Lett
(1991). Tumor angiogenesis and metastasis -correlation in invasive breast carcinoma.
(1993). Tumor angiogenesis: Review of current applications in tumor prognostication. Semin Diagn Pathol
(2004). Tumor lymphangiogenesis in head and neck squamous cell carcinoma: A morphometric study with clinical correlations. Cancer
(2005). Tumorsecreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis. Cancer Res
(2005). Upregulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors.
(2006). Vascular endothelial growth factor-D and its receptor VEGFR-3: two novel independent prognostic markers in gastric adenocarcinoma.
(2007). VEGF-C and VEGF-A synergistically enhance lymph node metastasis of gastric cancer. Biol Pharm Bull
(2006). Walgenbach KJ: Detection of lymphatic invasion in early stage primary colorectal cancer with the monoclonal antibody D2-40. Eur Surg Res